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Abstract The coagulation factor IXa (FIXa) exhibits a very 
weak proteolytic activity towards natural or synthetic substrates. 
Upon complex formation with its cofactor FVIIIa and Ca2+-
mediated binding to phospholipid membranes, FIXa becomes a 
very potent activator of FX. The presence of FVIIIa has no effect 
on the cleavage of peptide substrates by FIXa, however. We 
found that several alcohols dramatically enhance the catalytic 
activity of human FIXa towards synthetic substrates. Substrates 
with the tripeptidyl moiety R-D-Xxx-Gly-Arg are especially 
susceptible to the enhanced FIXa catalysis. Maximal increase up 
to 20-fold has been measured in the presence of ethylene glycol. 
We suggest that alcohols modify the conformation of FIXa 
rendering the active-site cleft more easily accessible to tripeptide 
substrates with a hydrophobic residue in the P3-position. 
© 1997 Federation of European Biochemical Societies. 
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of high catalytic activity [8]. FIXa displays several character-
istic differences, however. 
Its essential role in the coagulation cascade suggests FIXa 
could be an important target for drug design and diagnostic 
efforts. The low catalytic activity and the lack of suitable 
synthetic substrates limit direct chromogenic or fluorogenic 
assays. Instead, FIXa is assayed under physiological condi-
tions by activation of FX followed by chromogenic determi-
nation of resulting FXa activity. This indirect test is clearly 
disadvantageous in a variety of biotechnological fields, e.g. 
screening of inhibitors, which are well established for other 
coagulation enzymes. 
In this report, we show that certain alcohols dramatically 
increase the catalytic activity of FIXa towards several syn-
thetic substrates. This finding opens the way for direct FIXa 
assays in a variety of applications. The molecular aspects of 
this effect are discussed in terms of the X-ray crystal structure 
and the observed active site geometry of FIXa. 
1. Introduction 
The blood coagulation factor IXa is a trypsin-like serine 
proteinase circulating as a single-chain zymogen FIX in the 
plasma [1,2]. In the course of coagulation, FIX is activated 
and converted to its two-chain form FIXa[3 by the TF-FVIIa 
complex in cooperation with FXa and FXIa [3,4]. On phos-
pholipid surfaces FIXa(3 assembles in a calcium-dependent 
fashion with factor Villa forming the so-called intrinsic 
Xase [5]. Its importance in the coagulation process is indicated 
by the bleeding disorders caused by mutations in either com-
ponent : mutations in FVIII cause hemophilia A, whereas mu-
tations in FIX give rise to hemophilia B [6]. 
FIXa possesses interesting enzymatic and structural proper-
ties. Compared to other coagulation enzymes, it exhibits only 
extremely weak proteolytic activity against natural or syn-
thetic substrates in the absence of the cofactor FVIIIa [5]. 
However, complex formation with FVIIIa on the phospholi-
pid surface leads to a potent activator of factor X [5,7], while 
the catalytic activity towards synthetic substrates is not en-
hanced [5]. The recently solved X-ray crystal structure of ac-
tive-site inhibited full-length porcine FIXa shows an active-
site geometry similar to that of other trypsin-like proteinases 
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2. Materials and methods 
2.1. Materials 
Human FlXapS, FXa, FXIa, FXIIa and plasma kallikrein were 
purchased from Kordia (Leiden, The Netherlands). Bovine thrombin 
was prepared according to Walsmann [9]. N-terminally truncated re-
combinant FIXa comprising the EGF-2 domain and the catalytic 
domain was prepared as described elsewhere [10]. The chromogenic 
peptide substrates MOC-D-Nle-Gly-Arg-pNA, MS-D-HHT-Gly-
Arg-pNA, MS-D-CHG-Gfy-Arg-pNA and Z-Glu-Gly-Arg-pNA 
were supplied by Pentapharm Ltd. (Basel, Switzerland); Bz-Ile— 
Glu-Gly-Arg-pNA (S-2222) was from Haemochrom Diagnostica 
GmbH (Essen, Germany). All reactions were performed in Tris buffer 
at 25°C (0.05 M Tris, 0.1 M NaCl, 5 mM CaCl2, pH 7.4). The 
alcohols were from Sigma (Deisenhofen, Germany). The alcohols 
and all other chemicals used were of analytical grade. 
2.2. Influence of alcohols on the catalytic activity of FIXa and of other 
enzymes 
The measurements were carried out on a microplate reader (MR 
5000, Dynatech, Denkendorf, Germany) at 25°C. The test medium 
consisted of 200 ill Tris buffer containing 0-60% of the respective 
alcohol, 25 (il of aqueous substrate solution (10 mM) and 20 (il of 
enzyme solution. The change in optical density was measured at 
405 nm. The following concentrations were used for the different 
enzymes: FIXa (0.14 uM), rFIXa (0.48 uM), FXa (0.0016 uM), 
FXIa (0.0012 uM), FXIIa (0.0045 U/ml), plasma kallikrein 
(0.018 U/ml). The assays were performed in triplicate. 
2.3. Determination of kinetic constants 
Twenty-five microlitres of aqueous substrate solution and 20 j_il of 
enzyme solution were added to 200 ul of Tris buffer (without or with 
25% ethanol or 40% ethylene glycol, respectively). At least five con-
centrations of the substrate (between 0.25 and 4 mM) were used. The 
concentration of FIXa was 0.1 \iM, and that of rFIXa was 0.48 |iM. 
The measurements were carried out on a microplate reader at 25°C. 
Kinetic constants were determined from the initial rates of hydrolysis 
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using Lineweaver-Burk plots. A linear regression programme was 
used for calculation of the contants. The constants reported are means 
from at least three determinations. 
3. Results 
3.1. Enhancing effect of ethanol on the catalytic activity of 
FIXa 
We screened several chromogenic tripeptide substrates for 
activity with human FIXa and found very low catalytic activ-
ity. As described by Castillo et al. [11], the regression lines in 
Lineweaver-Burk plots go approximately through the origin, 
allowing determination of the specificity constants kcaXIKm 
only. For all the substrates tested, the substrate concentration 
was probably much lower than Km. As substrate concentra-
tions could not be increased due to their limited solubility, we 
used different additives to dissolve substrates at high concen-
trations. To our surprise we found that ethanol greatly enhan-
ces the catalytic activity of FIXa, especially for F X a sub-
strates of the type R-D-Xxx-Gly-Arg-pNA. In contrast to 
the results obtained in the absence of alcohol, the Lineweav-
er-Burk plots yielded straight lines intersecting the ^-axis near 
but not through the origin, indicating that the substrate con-
centrations were in the range of Km. Using recombinant hu-
man F IXa (rFIXa), an identical enhancing effect was found 
with ethanol and other alcohols. Due to its availability and 
purity, rF IXa was used for further study of the effect of a 
panel of different alcohols and other cosolvents on catalytic 
activity. The substrate M S - D - H H T - G l y - A r g - p N A was used 
for most of the experiments. 
3.2. Influence of alcohols on the catalytic activity of rFIXa 
Among the monohydric alcohols, ethanol potentiated the 
activity of rF IXa nearly 6-fold and methanol nearly 4-fold 
(Fig. 1A). The maximal enhancing effect was found at an 
alcohol concentration (v/v) of 25%. Both n- and /-propanol 
as well as r-butanol up to a concentration of 10% likewise 
increased the catalytic activity, while higher concentrations 
lead to a drastic activity decrease compared to alcohol-free 
buffers. Some other alcohols, e.g. w-butanol, «-amyl alcohol 
and w-octanol, showed similar enhancing effects at low con-
centrations; they were, however, not miscible with buffers at 
concentrations higher than 10%. 
The most striking effect on the catalytic activity of rF IXa 
was found for the dihydric alcohol ethylene glycol (Fig. IB). 
The rate of cleavage of the substrate M S - D - H H T - G l y - A r g -
p N A was enhanced more than 10-fold. In contrast to ethanol 
and methanol, which attained maximal effects at concentra-
tions between 15 and 25%, the catalytic activity of rF IXa 
became maximal at ethylene glycol concentrations between 
25 and 40%. Of the other dihydric alcohols, only 1,2-propane-
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Fig. 1. Influence of monohydric (A) as well as dihydric alcohols and 
glycerol (B) on the cleavage of MS-D-HHT-Gly-Arg-pNA (1.02 
mM) by rFIXa (0.48 uM) at pH 7.4. vo: Initial velocity without al-
cohol; v: initial velocity in the presence of alcohol; alcohols: meth-
anol (□), ethanol (o), n-propanol ( A ) , /-propanol (*), /-butanol 
(■&), ethylene glycol (•), 1,2-propanediol ( A ) , 1,3-propanediol ( T ) , 
glycerol (■). 
diol caused a noteworthy increase in enzyme activity, with a 
concentration dependence resembling that of ethylene glycol. 
Dihydric alcohols with a larger separation between the two 
hydroxyl groups such as 1,3-propanediol (Fig. IB) and 1,4-
butanediol (not shown here) affected the rF IXa activity only 
to a slight extent. 
Another concentration dependence was found for alcohols 
possessing even more hydroxyl groups. With glycerol, rF IXa 
activity increased continuously up to 6-fold at a 50% concen-
tration (Fig. IB). The same concentration dependence was 
found with i'-erythritol (not shown here); the enhancing effect, 
however, amounted to 1.5-fold at maximum. 
Table 1 
Kinetic constants for cleaving FXa substrates by rFIXa at pH 7.4 in the absence and presence of 33% ethylene glycol (mean±SD) 
Substrate Concentration of ethylene glycol 
0% 33% 
"•cat'A.m 
(M^-s-1) 
^cat 
(s-1) 
Km 
(mM) 
^cat '-^m 
(M_1-s_ 
Amplification of kcat/Km 
MOC-D-Nle-Gly-Arg-pNA 51.4±6.8 2.01 ±0.88 3.62±1.59 558 ± 17 10.8 
MS-D-CHG-Gly-Arg-pNA 86.9 ±9.1 5.67±1.37 1.43±0.19 3920±450 45.1 
MS-D-HHT-Gly-Arg-pNA 82.3 ±7.9 6.11 ±1.50 5.99 ±1.62 1028 ± 34 12.5 
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Fig. 2. Influence of ethylene glycol on the catalytic activity of rFIXa (0.48 uM) at pH 7.4. A: Initial velocity; B: specificity constants fccat/ATm; 
substrates: MS-D-CHG-Gly-Arg-pNA (•), MS-D-HHT-Gly-Arg-pNA ( A ) , MOC-D-Nle-Gly-Arg-pNA (■), Bz-Ile-Glu-Gly-Arg-pNA (■&). 
The potentiating effect of ethylene glycol and glycerol was 
abolished by derivatisation of the hydroxyl groups. Diethylene 
glycol, for example, caused only a 2-fold potentiation of 
rFIXa activity. The same hold for ethylene glycol monometh-
yl ether and for the glycerol derivative glycidol (2,3-epoxy-l-
propanol) (not shown here). The polyhydric alcohol PEG in-
hibited substrate cleavage with increasing concentration. 
3.3. Influence of solvents on the catalytic activity of rFIXa 
Solvents lacking hydroxyl groups, such as dimethylformam-
ide, dioxane, acetone and acetonitrile inactivated rFIXa in a 
similar manner as PEG. The same effect was seen with hy-
droxyacetone, but also with urea and guanidinium. Dimethyl-
sulfoxide up to a concentration of 30% did not inhibit rFIXa's 
activity, but had only little potentiating effect (1.5-fold; not 
shown here). 
3.4. Effect of ethylene glycol on the cleavage of different 
substrates 
Using ethylene glycol, which showed the most remarkable 
enhancing effect on the catalytic activity of rFIXa (Fig. 1), the 
catalytic activity of rFIXa on different substrates was further 
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Fig. 3. Effect of ethanol (A) and ethylene glycol (B) on the cleavage 
of MS-D-HHT-Gly-Arg-pNA (1.02 mM) by native (•) and re-
combinant FIXa (o), plasma kallikrein (-fr), FXIIa (□), FXIa ( A ) , 
FXa ( T ) and thrombin (*) at pH 7.4. 
investigated (Fig. 2A). The strongest enhancement was found 
for the substrate MS-D-CHG-Gly-Arg-pNA in the presence 
of 33% ethylene glycol, with the initial velocity of substrate 
cleavage potentiating up to more than 20-fold. 
All substrates containing a D-amino acid in P3 displayed 
large enhancement effects in the presence of ethylene glycol. 
In contrast, substrates with an L-amino acid in P3 were hydro-
lyzed very slowly by FIXa, even in the presence of ethylene 
glycol or other alcohols. Fig. 2A displayed the cleavage rates 
for the selective FXa substrate Bz-Ile-Glu-Gly-Arg (S-2222). 
The velocities determined in the absence and presence of 33% 
ethylene glycol were very low (4.2 and 8.7 mOD/min, respec-
tively). Similarly low velocities were found with the substrate 
Z-Glu-Gly-Arg-pNA (not shown), reported by Cho et al. 
[12] to be the best IXa substrate. 
3.5. Determination of kinetic constants 
The plots of initial velocity data versus substrate concen-
tration were approximately linear for all substrates studied, 
indicating that the highest substrate concentrations never ap-
proached Km. Correspondingly, the regression lines in Line-
weaver-Burk plots ran through the origin disallowing resolu-
tion of individual Arcat and Km parameters. These Km values 
are probably above 10 mM. Values of kcsAIKm were deter-
mined to be very low for the substrates MOC-D-Nle-Gly-
Arg-pNA, MS-D-HHT-Gly-Arg-pNA and MS-D-CHG-
Gly-Arg-pNA (Table 1). 
At increasing concentrations of the effective alcohols, kcaJ 
Km increased dramatically. The dependence on ethylene glycol 
concentration for three different substrates is shown in Fig. 
2B. Maximal specificity constants were found for 33% ethyl-
ene glycol (Table 1). For the substrate MS-D-CHG-Gly-Arg-
pNA, the specificity constant kC!AIKm showed a 40-fold in-
crease, while the amplification was 10-fold in case of MOC-
D-Nle-Gly-Arg-pNA and MS-D-HHT-Gly-Arg-pNA. Due 
to this enhanced activity in the presence of ethylene glycol, 
individual Km values could also be determined amounting to 
1-10 mM (Table 1). 
3.6. Influence of ethylene glycol on other clotting enzymes 
Native and recombinant human FIXa were identical in ex-
hibiting this dramatic alcohol enhancement (Fig. 3). In stark 
contrast, the catalytic activity of other trypsin-like enzymes 
was decreased by alcohols. Fig. 3A,B show the effect of etha-
nol and ethylene glycol on the activity of other members of 
the intrinsic coagulation pathway, namely plasma kallikrein 
and factors Xa, XIa, Xlla and thrombin. Only plasma kallik-
rein tolerated alcohols up to a concentration of 10-15%, while 
all the other enzymes studied were inhibited. 
4. Discussion 
Fig. 4 shows the catalytic domain of porcine FIXa around 
the active site, with subsites SI to S3/S4 occupied by the 
D-Phe-Pro-Arg moiety of the covalently bound PPACK in-
hibitor [8]. Compared to FXa [13], the 99 loop of FIXa (chy-
motrypsinogen numbering) contains two additional residues. 
In FIXa, the phenolic side chain of Tyr" does not extend into 
the S2 subsite restricting it as in FXa, but is displaced to 
occupy the aromatic S3/S4 subsite. Thus, the medium sized 
proline ring of PPACK can be accommodated at the S2 sub-
site, while the benzyl side chain of its D-Phe residue cannot 
slot into the S3/S4 subsite, presumably giving rise to a non-
optimal overall binding of the inhibitor. The Arg side chain of 
PPACK is inserted into the SI pocket of FIXa in the usual 
manner, i.e. with its distal guanidino group hydrogen bond/ 
salt bridge connected with the Asp189 carboxylate and Glu219 
O. In the crystal structure of FIXa, this latter carbonyl is only 
weakly defined by electron density, suggesting some oscilla-
tion caused by a tensed conformation energetically favourable 
only for Gly residues. Glu219 is strictly conserved in all FIX 
species sequenced so far, but is replaced by a glycine in all 
other serine proteinases with a trypsin-like SI pocket. In free 
FIXa, this SI pocket is assumed to be partially closed (cryp-
tic), what would be in good agreement with the extremely low 
affinity of benzamidine and related SI accommodating inhib-
itors for FIXa [8]. 
The geometries of both the S3/S4 cleft and the SI pocket 
might be modified externally, e.g. by certain alcohols in an as 
yet unknown manner. A possibility is that interaction with 
alcohols restores deformed or structurally flexible patches in 
the active site of FIXa. Alternatively, specific alcohols could 
influence surface conformations in the vicinity of Tyr99, most 
likely the loop comprising residues 94-99; this could lead to a 
removal of the unfavorable interactions mentioned before for 
D-configurated P3 residues. This would allow a more precise 
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Fig. 4. PPACK bound to the active site of FIXa (displayed as stick model) superimposed with a Connolly dot surface; according to [8]. The 
Sl-specificity pocket (central hole) opens to the left of the catalytic triad residues Ser195, His57 and Asp102. The Pl-Arg side chain of PPACK 
extends into this SI-pocket forming a salt bridge to Asp189 (not shown) and a hydrogen bond to the carbonyl oxygen of Glu219. P2-Pro and 
P3-D-Phe of PPACK contact the side chains of Lys98 and Tyr99, which are part of the 99 loop. 
binding at the active site, with beneficial effects on the cata-
lytic efficiency. This hypothesis seems to be corroborated 
somewhat by the much larger catalytic activity enhancement 
for substrates containing a D-amino acid compared to sub-
strates containing an L-amino acid at P3. For tripeptidyl sub-
strates that bind with an extended conformation, only side 
chains of D-configured P3 residues will interact with S3/S4 
and might thus collide with Tyr". Further support of this 
hypothesis comes from mutational analyses [10]; transplanta-
tion of the 99 loop of FXa to FIXa increases the catalytic 
activity towards /ccat and Km values similar to those observed 
for FIXa in the presence of ethylene glycol. 
It is unlikely that this alcohol effect is brought about by a 
change in the dielectric constant of the solvent. Rather, the 
differential effects of the various alcohols point to interactions 
at a distinct binding site. Both the number and the position of 
hydroxyl groups as well as the number of separating methyl-
ene groups is of paramount importance. The amplification by 
monohydric alcohols increases in the order r-butanol < /-pro-
panol < n-propanol < methanol < ethanol. Thus, a hydroxy-
methyl group with one adjacent methyl group seems optimal. 
In the case of two hydroxyl groups, one adjacent methyl 
group is tolerated. The ranking order of the most effective 
alcohols is ethanol < 1,2-propanediol < ethylene glycol. The 
effect observed with 1,3-propanediol is only 10-15% of that 
seen with ethylene glycol or 1,2-propanediol, respectively; 
thus, intervening methylene groups have detrimental effects 
on the effectiveness of alcohols. 
An important result of this work is that FIXa shows in-
creased activity in the presence of certain alcohols. This find-
ing opens the possibility for simple direct chromogenic or 
fluorogenic assays for determination of active FIXa; it facil-
itates many applications such as screening for specific inhib-
itors directed against FIXa as potential antithrombotic drugs, 
or routine diagnostics of FIX and FIXa in plasma or plasma 
products. The fact that other coagulation enzymes, especially 
the more abundant FXa and thrombin, are inhibited by alco-
hols is of great importance, since side reactions due to the 
presence of these enzymes would be depressed. 
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